The global skin care supplement market size is calculated at USD 4.14 billion in 2024, grew to USD 4.47 billion in 2025, and is predicted to hit around USD 8.94 billion by 2034, poised to grow at a CAGR of 8% between 2024 and 2034. The Asia Pacific skin care supplement market size accounted for USD 1.95 billion in 2024 and is anticipated to grow at the fastest CAGR of 8.12% during the forecast year.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Skin Care Supplement Market
5.1. COVID-19 Landscape: Skin Care Supplement Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Skin Care Supplement Market, By Formulation
8.1. Skin Care Supplement Market Revenue and Volume, by Formulation, 2024-2034
8.1.1. Capsules
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Tablets
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
8.1.3. Powders
8.1.3.1. Market Revenue and Volume Forecast (2021-2034)
8.1.4. Liquids
8.1.4.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 9. Global Skin Care Supplement Market, By Distribution Channel
9.1. Skin Care Supplement Market Revenue and Volume, by Distribution Channel, 2024-2034
9.1.1. Online
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Offline
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 10. Global Skin Care Supplement Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Volume Forecast, by Formulation (2021-2034)
10.1.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, by Formulation (2021-2034)
10.1.3.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, by Formulation (2021-2034)
10.1.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, by Formulation (2021-2034)
10.2.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, by Formulation (2021-2034)
10.2.3.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, by Formulation (2021-2034)
10.2.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, by Formulation (2021-2034)
10.2.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, by Formulation (2021-2034)
10.2.6.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, by Formulation (2021-2034)
10.3.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, by Formulation (2021-2034)
10.3.3.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, by Formulation (2021-2034)
10.3.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, by Formulation (2021-2034)
10.3.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, by Formulation (2021-2034)
10.3.6.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, by Formulation (2021-2034)
10.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, by Formulation (2021-2034)
10.4.3.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, by Formulation (2021-2034)
10.4.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, by Formulation (2021-2034)
10.4.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, by Formulation (2021-2034)
10.4.6.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, by Formulation (2021-2034)
10.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, by Formulation (2021-2034)
10.5.3.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, by Formulation (2021-2034)
10.5.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
Chapter 11. Company Profiles
11.1. The Boots Company PLC
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Amway
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Hum Nutrition Inc
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Murad, Inc
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Perricone MD
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Neutrogena
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Meiji Holding Co., Ltd
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Shiseido Company
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Beiersdorf AG
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Loreal SA
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client